Thông tin thuốc của Antithymocyte immunoglobulin, rabbit

Thông tin này không áp dụng cho tất cả các quốc gia. Vui lòng tham khảo thông tin kê toa lưu hành tại Việt Nam.

Thông tin thuốc gốc

Chỉ định và Liều dùng

Intravenous
Treatment of kidney transplant rejection

Adult: For the treatment of corticosteroid-resistant cases: In combination with other immunosuppressive agents: 1.5 mg/kg daily for 7-14 days. Doses are given via IV infusion, using a 0.22 µmeter in-line filter; administer the 1st dose over at least 6 hours and then the subsequent doses over at least 4 hours. Premedicate with corticosteroids, antihistamines, and/or antipyretics 1 hour before administration. Dose interruption or discontinuation may be required according to individual safety or tolerability; dosage and treatment recommendations may vary among countries and individual products (refer to specific product guidelines).
Child: Same as adult dose.

Intravenous
Prophylaxis of rejection in kidney graft transplant

Adult: In combination with other immunosuppressive agents: 1-1.5 mg/kg daily for 3-9 days. Alternatively, 1.5 mg/kg daily for 4-7 days. Doses are given via IV infusion, using a 0.22 µmeter in-line filter; administer the 1st dose over at least 6 hours and then the subsequent doses over at least 4 hours. Premedicate with corticosteroids, antihistamines, and/or antipyretics 1 hour before administration. Dose interruption or discontinuation may be required according to individual safety or tolerability; dosage and treatment recommendations may vary among countries and individual products (refer to specific product guidelines).
Child: Same as adult dose.

Intravenous
Prophylaxis of rejection in cardiac graft transplant

Adult: In combination with other immunosuppressive agents: 1-2.5 mg/kg daily for 3-5 days. Doses are given via IV infusion, using a 0.22 µmeter in-line filter; administer the 1st dose over at least 6 hours and then the subsequent doses over at least 4 hours. Premedicate with corticosteroids, antihistamines, and/or antipyretics 1 hour before administration. Dose interruption or discontinuation may be required according to individual safety or tolerability; dosage and treatment recommendations may vary among countries and individual products (refer to specific product guidelines).
Child: Same as adult dose.

Hướng dẫn pha thuốc

Reconstitute with 5 mL of sterile water for inj. Gently rotate until completely dissolved. Further dilute the reconstituted solution with NaCl 0.9% or dextrose 5% in water to a total volume of 50-500 mL, depending on the total number of vials needed. Gently invert the infusion bag once or twice to mix.

Tương kỵ

Precipitation may occur with heparin and hydrocortisone in a dextrose infusion solution.

Chống chỉ định

Hypersensitivity. Active acute or chronic infections which prevent additional immunosuppression.

Thận trọng

Patients who have recently received antithymocyte immunoglobulin (rabbit) should not be given attenuated live vaccines. Obese patients. Hepatic impairment. Children. Pregnancy.

Tác dụng không mong muốn

Significant: Haematologic effects (e.g. thrombocytopenia, leucopenia, neutropenia, lymphopenia), hypersensitivity.
Blood and lymphatic system disorders: Febrile neutropenia.
Cardiac disorders: Tachycardia.
Gastrointestinal disorders: Nausea, diarrhoea, dysphagia, vomiting, constipation.
General disorders and administration site conditions: Inj site pain, swelling, erythema; fever, shivering.
Hepatobiliary disorders: Hepatocellular injury, hepatotoxicity, hepatic failure.
Infections and infestations: UTI.
Investigations: Increased transaminases.
Metabolism and nutrition disorders: Hyperkalaemia, hypokalaemia, acidosis, hyperphosphataemia, hyperlipidaemia.
Musculoskeletal and connective tissue disorders: Myalgia.
Psychiatric disorders: Insomnia, anxiety.
Respiratory, thoracic and mediastinal disorders: Dyspnoea.
Skin and subcutaneous tissue disorders: Rash, pruritus.
Vascular disorders: Hypotension, hypertension.
Potentially Fatal: Cytokine release syndrome (including cardiopulmonary events); malignancies (e.g. lymphoma, lymphoproliferative disorders). Rarely, anaphylactic reactions, infections (bacterial, fungal, viral, and protozoal), reactivation of infection (e.g. cytomegalovirus infection), sepsis.

Chỉ số theo dõi

Evaluate patient for sensitivity to rabbit protein before administration. Monitor lymphocyte count (total lymphocyte and/or T-cell subset), CBC with differential, platelet count, vital signs. Assess for signs and symptoms of anaphylactic shock and infection.

Tương tác

May increase the risk of vaccine-associated infection.

Ảnh hưởng đến kết quả xét nghiệm

May interfere with rabbit antibody-based immunoassays, cross-match or panel-reactive antibody cytotoxicity assays, and enzyme-linked immunosorbent assay (ELISA) tests.

Tác dụng

Description:
Mechanism of Action: Antithymocyte immunoglobulin (rabbit), a polyclonal antibody preparation, is a selective immunosuppressive agent (primarily acting on T lymphocytes). The exact mechanism of immunosuppression has not been fully elucidated; however, it may be attributed to peripheral and central lymphocyte depletion.
Synonym(s): Antilymphocyte immunoglobulin, rabbit.
Onset: T-cell depletion: Within 24 hours.
Duration: Lymphopenia: Up to 1 year.
Pharmacokinetics:
Excretion: Elimination half-life: 2-3 days.

Bảo quản

Intact vial: Store between 2-8°C. Do not freeze. Protect from light. Reconstituted or diluted solution: Store between 2-8°C for 24 hours. Storage recommendations may vary among countries or individual products. Refer to specific product guidelines.

Phân loại MIMS

Thuốc ức chế miễn dịch

Phân loại ATC

L04AA04 - antithymocyte immunoglobulin (rabbit) ; Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.

Tài liệu tham khảo

Anon. Antithymocyte Globulin (Rabbit). AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 24/05/2023.

Anon. Antithymocyte Globulin (Rabbit). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 24/05/2023.

Buckingham R (ed). Antilymphocyte Immunoglobulins. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 24/05/2023.

Joint Formulary Committee. Antithymocyte Immunoglobulin (Rabbit). British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 24/05/2023.

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics. Thymoglobuline Powder for Infusion data sheet 20 June 2022. Medsafe. http://www.medsafe.govt.nz. Accessed 24/05/2023.

Thymoglobulin Injection, Powder, Lyophilized, for Solution (Genzyme Corporation). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 24/05/2023.

Thymoglobuline 25 mg Powder for Solution for Infusion (Genzyme Europe B.V.). MHRA. https://products.mhra.gov.uk. Accessed 24/05/2023.

Thymoglobuline 5 mg/mL (Sanofi-Aventis [Malaysia] Sdn. Bhd.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 24/05/2023.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Antithymocyte immunoglobulin, rabbit từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com